1. Home
  2. GMAB vs SN Comparison

GMAB vs SN Comparison

Compare GMAB & SN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GMAB

Genmab A/S ADS

HOLD

Current Price

$33.15

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Logo SharkNinja Inc.

SN

SharkNinja Inc.

HOLD

Current Price

$191.66

Market Cap

21.1B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMAB
SN
Founded
1999
1993
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3B
21.1B
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
GMAB
SN
Price
$33.15
$191.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
8
Target Price
$39.56
$133.13
AVG Volume (30 Days)
2.9M
1.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
1.77
Revenue
N/A
$6,399,188,000.00
Revenue This Year
$17.85
$15.22
Revenue Next Year
$16.04
$10.74
P/E Ratio
$1.90
$107.93
Revenue Growth
N/A
15.75
52 Week Low
$23.62
$83.12
52 Week High
$35.43
$194.54

Technical Indicators

Market Signals
Indicator
GMAB
SN
Relative Strength Index (RSI) 60.43 69.12
Support Level $30.68 $177.15
Resistance Level $34.32 $191.22
Average True Range (ATR) 0.67 5.18
MACD -0.05 -0.38
Stochastic Oscillator 63.49 79.90

Price Performance

Historical Comparison
GMAB
SN

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

About SN SharkNinja Inc.

SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment, and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The Company has identified two operating segments, Domestic and International. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.

Share on Social Networks: